Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Gosch, Martin Madaus, Francis Lunger, Kevin Farr, Michael Schrader

Premium

Gregory Gosch has been named vice president of marketing for Luminex. Before joining Luminex, Gosch served as senor director of sales and marketing for Nanogen, headquartered in San Diego. He has also held marketing and product-management positions for Chiron and Bio-Rad Laboratories.


Millipore said last week that it has appointed Martin Madaus as president and CEO, effective no later than Feb. 1, 2005. Maduas will replace Francis Lunger, who will remain as chairman of the board during the transition. Maduas will also join Millipore’s board of directors, the company said.

Maduas joins Millipore from Roche Diagnostics, where he was president and CEO, Millipore said. Prior to his appointment as president and CEO in 2000, Maduas was vice president of business development at Roche Diagnostics. He has also held positions at Boehringer Mannheim, which was acquired by Roche in 1998. Maduas holds a PhD in veterinary medicine.


Kevin Farr has been elected to the board of directors of Beckman Coulter, effective Oct. 8, the company said last week. He is the chief financial officer for Mattel. Farr holds an MBA from Northwestern University and a bachelor’s degree from Michigan State University.


Michael Schrader, the co-founder and chief technology officer of BioVisioN is planning to move back to academia, according to a statement released last week. He has been appointed to a professorship in physical chemistry and instrumental analysis at the Department of Biotechnology and Bioinformatics at the University of Applied Sciences Weihenstephan in Freising, Germany.

“This is an excellent opportunity to harvest ten years of experience in the jump-started German biotech scene by teaching young engineers the skills necessary for working in this type of industry,” said Scrader.

 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.